Overview
Utilization Management (UM) is the set of processes by which payers and healthcare organizations review the medical necessity, appropriateness, and efficiency of healthcare services being planned or delivered. UM serves the dual purpose of controlling cost (preventing inappropriate care) and promoting quality (ensuring evidence-based care). It is the primary machinery by which coverage decisions happen beyond the automated level — when clinical judgment is needed, UM handles the review.
UM operates at three temporal points. Prospective UM is prior authorization — pre-service review of whether a planned service meets medical-necessity criteria. Concurrent UM is review during care, typical for inpatient stays — daily review of continued inpatient criteria, step-down appropriateness, and discharge readiness. Retrospective UM is post-service review — typically claims auditing for coding, medical-necessity, and appropriateness, often tied to payer post-payment audit programs or provider internal audits.
Clinical criteria drive UM decisions. Widely-used criteria sets include InterQual (Change Healthcare) and MCG (Milliman Care Guidelines) — subscription-based clinical decision tools that define when specific procedures, admissions, or services meet medical-necessity thresholds. Payers may use commercial criteria or develop proprietary criteria; providers use the same or different criteria internally. Criteria misalignment between provider and payer is a common source of UM disputes.
UM staffing typically includes nurse reviewers (first-line review), physician advisors (escalation for complex cases), and medical directors (final adjudication for appealed cases). The review workflow is: case referral with clinical documentation, nurse review against criteria, approval or referral to physician advisor for cases not clearly meeting criteria, final adjudication. Timely review is a regulatory expectation — ERISA, ACA, and state laws set turnaround deadlines (often 72 hours for urgent authorizations, longer for non-urgent).
For providers, UM interactions are a core revenue cycle activity. Getting prior authorizations right, providing timely clinical documentation for concurrent review, and defending medical necessity on retrospective audit are daily work. Building strong relationships with payer UM teams — understanding their criteria, preferred documentation styles, and escalation paths — reduces UM-related denials and speeds coverage decisions.
From a board-reporting standpoint, Utilization Management belongs in the compliance committee's quarterly dashboard. The reporting line should include volume, exception rate, and any open remediation action; reviewers tie Utilization Management metrics to the broader compliance program KPIs so an emerging Utilization Management risk surfaces before it becomes a formal finding. Pairing the Utilization Management trend with utilization review gives the committee a single view of whether the control environment is strengthening or drifting.
Compliance programs treat Utilization Management as a recurring audit trigger rather than a one-time policy exercise. The practical approach is a quarterly Utilization Management self-audit tied into the broader compliance calendar, with findings tracked against utilization review and prior authorization so a Utilization Management gap cannot silently persist from one audit cycle to the next. Reviewers on this site pair every Utilization Management reference with the corresponding regulatory citation so the policy owner can trace the requirement back to its authoritative source.
Industry benchmark
URAC UM accreditation standards. NCQA UM accreditation. InterQual and MCG clinical criteria are the industry dominant reference. URAC UM turnaround standards for urgent (72 hours), non-urgent (~14 days).
Worked example
A payer's UM nurse reviews a request for an inpatient admission for a patient with chest pain. InterQual criteria: patient meets admission criteria for unstable chest pain with elevated troponin and positive stress result — approved. The UM case takes 20 minutes of nurse time with chart review; approval is documented and the patient is admitted. Had criteria not been clearly met, the case would escalate to the payer's medical director for physician review.
Frequently asked questions — Utilization Management
What's the difference between UM and UR?
Historically the terms are used interchangeably. Some organizations use UR (Utilization Review) for the specific review activity and UM (Utilization Management) for the broader function that includes UR plus operational oversight. In common usage, most people treat them as synonyms.
What criteria do payers use for UM?
Most commonly InterQual (Change Healthcare) or MCG (Milliman Care Guidelines) for inpatient and post-acute decisions. Payers may also have proprietary criteria or policy documents for specific services. Government programs (Medicare, Medicaid) have their own LCDs, NCDs, and state Medicaid policies.
Is UM applied to all services or only some?
Mostly the services payers consider higher cost or higher-variation in appropriateness. Every payer has a PA list of services requiring prospective review. Inpatient admissions typically get concurrent review. High-cost imaging, surgery, specialty pharmaceuticals, DME, home health — common UM targets. Low-cost routine services are usually auto-adjudicated without UM.
Can providers challenge UM decisions?
Yes. Peer-to-peer review (provider-to-payer-medical-director discussion) is the first escalation. Formal appeals follow standard claim-appeal procedures. External Independent Review Organization (IRO) review is available for medical-necessity disputes under most state laws and ACA rules.
Disclaimer
This glossary entry is operational reference for revenue-cycle and medical-billing professionals. It is not legal, clinical, or contractual advice. Industry benchmarks cite named public sources where available; always verify against the current guidance from the authority body before relying on a number in a contract, policy, or compliance filing.